News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
New hope in treating advanced grade 3 Neuroendocrine Neoplasms – Garcia-Carbonero’s Lab
Photo of Rocio Garcia-Carbonero taken from consejosdetufarmaceutico.com
Aug 10, 2024, 13:59

New hope in treating advanced grade 3 Neuroendocrine Neoplasms – Garcia-Carbonero’s Lab

Garcia-Carbonero’s Lab shared a post on X:

“New hope in treating advanced grade 3 Neuroendocrine Neoplasms!

 The NICE-NEC trial (GETNE-T1913) shows Nivolumab and platinum-doublet chemo can extend survival for over a third of patients.

Median OS: 13.9 months; 37.6% are long-term survivors.”

Neuroendocrine

Source: Garcia-Carbonero’s Lab/X

Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913).

Authors: Maria Carmen Riesco-Martinez, Jaume Capdevila, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo, Yolanda Rodriguez-Gil, Beatriz Soldevilla and Rocio Garcia-Carbonero.

Neuroendocrine

Alex Teule Ana Custodio Ana Teijo Arantza Lamas-Paz Beatriz Anton-Pascual Beatriz Soldevilla cancer Eduardo Polo Enrique Grande Garcia-Carbonero's Lab Isabel Sevilla Jaume Capdevila Jorge Hernando Maria Carmen Riesco-Martinez Marta Benavent Neuroendocrine Neoplasms NICE-NEC trial nivolumab OncoDaily Oncology Oscar Alfredo Castillo-Trujillo Paula Jimenez-Fonseca Rocio Garcia-Carbonero Teresa Alonso-Gordoa Vicente Alonso Yolanda Rodriguez-Gil
Special Coverage
Blog
Dec 21, 2024, 12:18
NCI Symposium on Translational Technology for Global Health
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story
Blog
Dec 21, 2024, 11:24
Christy Brown: How many things can you dread more than 'your child has aggressive brain cancer?'
Blog
Dec 21, 2024, 11:18
Jose Fernando Moura: Pivotal SABCS24 summary hosted by Cancer Network
Blog
Dec 21, 2024, 11:18
Jérôme Salomon: President Macron, WHO Director-General and global health leaders inaugurate WHO Academy
Blog
Dec 21, 2024, 11:17
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Blog
Dec 21, 2024, 11:14
Mediamedic - Wenbin Zhou on Pyrotinib-based regimen in HER2-positive breast cancer